Barbiturate Toxicity & Urinary Alkalinization
Comprehensive emergency evaluation and protocolized management of barbiturate poisonings: short-acting (pentobarbital, secobarbital) vs. long-acting (phenobarbital, primidone) agents, prolonged GABA-A chloride channel opening, profound central nervous and respiratory depression, hypothermia, cardiovascular collapse, barbiturate bullae ('coma blisters'), urinary alkalinization protocols for phenobarbital, Multidose Activated Charcoal (MDAC), and hemodialysis indications.
Resuscitation Quick Actions • First 2 Minutes
Urinary Alkalinization
Sodium Bicarbonate 150 mEq in 1L D5W at 150–200 mL/hr; target urine pH 7.5–8.0 (effective ONLY for phenobarbital, pKa 7.2)
Multidose Charcoal (MDAC)
Activated Charcoal 50g initial, then 25g q2–4h; performs 'gastrointestinal dialysis' by binding phenobarbital in enterohepatic circulation
Coma Blisters (Bullae)
Tense clear/hemorrhagic bullae over bony pressure points; sterile dressing, avoid debridement
Barbiturate vs Benzo
Barbiturates can directly open GABA-A channels without GABA at high doses (no ceiling effect; can cause fatal asystole)
Hemodialysis Threshold
Level > 100 mcg/mL in acute phenobarbital, refractory hypotension, coma with respiratory failure, or renal impairment
Avoid Analeptics
Flumazenil is completely INEFFECTIVE against barbiturates; CNS stimulants are contraindicated
Bottom-Line Clinical Pearl
Barbiturates potentiate GABA-A signaling by increasing the DURATION of chloride channel opening (in contrast to benzodiazepines, which increase frequency). Overdose produces deep coma, respiratory arrest, hypothermia, hypotension, and pathognomonic cutaneous barbiturate bullae (tense non-erythematous blisters over pressure points). Short-acting barbiturates carry high mortality and cannot be eliminated by alkalinization. Long-acting phenobarbital is a weak acid (pKa 7.2) that can be cleared via urinary alkalinization (urine pH 7.5–8.0 with IV sodium bicarbonate) and Multidose Activated Charcoal (MDAC); severe poisonings with shock or renal failure require intermittent hemodialysis.
Barbiturates bind allosteric sites on the pentameric GABA-A receptor complex. While benzodiazepines increase the frequency of chloride channel opening and require endogenous GABA to function (creating a safety ceiling effect), barbiturates increase the duration of chloride channel opening. Furthermore, at elevated toxic concentrations, barbiturates can directly gate and open the chloride channel even in the complete absence of GABA, while simultaneously depressing excitatory AMPA/kainate glutamate receptors. This eliminates any pharmacodynamic ceiling effect, producing profound, life-threatening medullary cardiovascular and respiratory arrest.
| Elimination Modality | Mechanism & Administration | Clinical Utility & Limitations |
|---|---|---|
| Urinary Alkalinization | 150 mEq Sodium Bicarbonate in 1L D5W titrated to urine pH 7.5 to 8.0 | Effective ONLY for phenobarbital (pKa 7.24). Alkalinizing urine ionizes phenobarbital into its impermeable conjugate base, preventing reabsorption in the proximal renal tubule. Completely ineffective for short-acting barbiturates (e.g., secobarbital, pentobarbital; pKa > 7.9). |
| Multidose Activated Charcoal (MDAC) | Initial dose 50g orally or via NG tube, followed by 25g every 2 to 4 hours | Enhances non-renal elimination via gastrointestinal dialysis and interrupts enterohepatic circulation. Requires a secure airway (intubation) to prevent fatal charcoal pulmonary aspiration. |
| Intermittent Hemodialysis | Vascular catheter access with high-efficiency dialyzer | Indicated for serum phenobarbital concentrations > 100 mcg/mL, refractory shock, prolonged coma, or acute renal failure. Clears phenobarbital rapidly due to low molecular weight and moderate protein binding. |
Test Your Barbiturate Toxicity & Urinary Alkalinization Clinical Acumen
Directly launch an active-recall practice block from our 8,400+ validated COMLEX Level 1, 2-CE & 3 board question bank with complete explanations.
Related Emergency Protocols & Differentials
Salicylate Toxicity & Urinary Alkalinization
Mechanisms and protocols for urinary alkalinization.
Open Protocol Related EM ProtocolAltered Mental Status & Coma
Systematic evaluation of toxic and metabolic coma.
Open Protocol Related EM ProtocolWithdrawal Syndromes & Substance Use Disorders
Life-threatening sedative-hypnotic withdrawal management.
Open Protocol